A detailed history of Beacon Investment Advisory Services, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 705,628 shares of DXCM stock, worth $48.1 Million. This represents 3.47% of its overall portfolio holdings.

Number of Shares
705,628
Previous 744,066 5.17%
Holding current value
$48.1 Million
Previous $103 Million 22.48%
% of portfolio
3.47%
Previous 4.5%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $4.24 Million - $5.4 Million
-38,438 Reduced 5.17%
705,628 $80 Million
Q1 2024

May 09, 2024

SELL
$114.22 - $140.1 $1.6 Million - $1.96 Million
-14,013 Reduced 1.85%
744,066 $103 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $1.67 Million - $2.74 Million
-22,070 Reduced 2.83%
758,079 $94.1 Million
Q3 2023

Oct 31, 2023

BUY
$86.06 - $137.93 $1.9 Million - $3.04 Million
22,062 Added 2.91%
780,149 $72.8 Million
Q2 2023

Jul 21, 2023

BUY
$112.47 - $130.98 $1.84 Million - $2.14 Million
16,375 Added 2.21%
758,087 $97.4 Million
Q1 2023

May 04, 2023

BUY
$104.0 - $122.92 $109,512 - $129,434
1,053 Added 0.14%
741,712 $86.2 Million
Q4 2022

Jan 13, 2023

SELL
$84.98 - $122.67 $2.31 Million - $3.33 Million
-27,162 Reduced 3.54%
740,659 $0
Q3 2022

Oct 20, 2022

SELL
$76.35 - $94.18 $458 - $565
-6 Reduced -0.0%
767,821 $61.8 Million
Q2 2022

Jul 21, 2022

BUY
$67.99 - $132.89 $39.2 Million - $76.6 Million
576,215 Added 300.72%
767,827 $57.2 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $250,535 - $346,722
-2,663 Reduced 1.37%
191,612 $98 Million
Q4 2021

Feb 04, 2022

SELL
$129.87 - $162.82 $98,441 - $123,417
-758 Reduced 0.39%
194,275 $104 Million
Q3 2021

Nov 09, 2021

SELL
$106.71 - $143.18 $1.36 Million - $1.82 Million
-12,700 Reduced 6.11%
195,033 $107 Million
Q2 2021

Aug 02, 2021

SELL
$80.99 - $107.93 $210,654 - $280,725
-2,601 Reduced 1.24%
207,733 $88.7 Million
Q1 2021

May 21, 2021

SELL
$84.79 - $104.74 $202,393 - $250,014
-2,387 Reduced 1.12%
210,334 $75.6 Million
Q4 2020

Feb 08, 2021

SELL
$78.0 - $104.5 $12,402 - $16,615
-159 Reduced 0.07%
212,721 $78.6 Million
Q3 2020

Oct 29, 2020

SELL
$95.51 - $112.95 $108,403 - $128,198
-1,135 Reduced 0.53%
212,880 $87.8 Million
Q2 2020

Jul 28, 2020

SELL
$62.68 - $105.34 $1.33 Million - $2.23 Million
-21,214 Reduced 9.02%
214,015 $86.8 Million
Q1 2020

May 05, 2020

SELL
$47.79 - $75.63 $1.21 Million - $1.91 Million
-25,222 Reduced 9.68%
235,229 $63.3 Million
Q4 2019

Jan 31, 2020

BUY
$36.62 - $57.29 $9.22 Million - $14.4 Million
251,651 Added 2859.67%
260,451 $57 Million
Q3 2019

Oct 29, 2019

BUY
$35.53 - $43.8 $252,263 - $310,980
7,100 Added 417.65%
8,800 $1.31 Million
Q2 2019

Aug 07, 2019

BUY
$27.84 - $38.92 $47,328 - $66,164
1,700 New
1,700 $255,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Beacon Investment Advisory Services, Inc. Portfolio

Follow Beacon Investment Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.